Dr Martens, the renowned footwear brand, welcomes Giles Wilson as its incoming Chief Financial Officer in 2024. Formerly associated with William Grant & Sons, a prominent global spirits company with brands like Glenfiddich Scotch Whisky and Hendrick’s Gin, Wilson’s extensive experience positions him as a valuable addition to the Dr Martens team.
Wilson takes the reins from Jon Mortimore, who, after announcing his retirement in April, graciously extends his commitment to the company until the end of the financial year. Mortimore played a crucial role in steering Dr Martens through substantial revenue growth from £230 million to £1 billion and facilitating the successful IPO in January 2021.
Chair Paul Mason expresses delight in Wilson’s appointment, stating, «Following a rigorous selection process, we are delighted to appoint Giles as CFO. He is a very capable finance leader with extensive experience in various sectors, and his time in the branded spirits industry provides a solid grounding in global brands and wholesale distribution management.»
CEO Kenny Wilson adds, «I am looking forward to working with him on the next phase of Dr Martens’ journey to become a £2 billion revenue footwear brand.» With Wilson’s expertise and Dr Martens’ iconic legacy, the future promises continued success for this celebrated footwear brand. Explore the next chapter of Dr Martens’ legacy with Giles Wilson at the financial helm.
